Rigel Pharmaceuticals Inc
RIGL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001034842
No open-market purchases or sales by Rigel Pharmaceuticals Inc insiders were filed in the last 90 days; 155 institutions reported holding it in 13F filings for Q2 2026, worth $640.4M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Rigel Pharmaceuticals Inc changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 117 | 91 | −26 |
| SharesConverted for a 1-for-10 split | 11.1M | 10.4M | −708.8K (−6.4%) |
| Value | $164.3M | $85.4M | −$78.9M (−48.0%) |
New holders (13)
Institutions that held Rigel Pharmaceuticals Inc at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Kennedy Capital Management, Inc. | 89,934 | $739.3K | 0.02% |
| HRT Financial LP | 27,687 | $227.0K | 0.00% |
| Ground Swell Capital, LLC | 17,094 | $140.5K | 0.14% |
| Corebridge Financial, Inc. | 9,365 | $77.0K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 8,623 | $70.9K | 0.00% |
| Picton Mahoney Asset Management | 453 | $3.00K | 0.00% |
| SRS Capital Advisors, Inc. | 85 | $699 | 0.00% |
| EverSource Wealth Advisors, LLC | 63 | $667 | 0.00% |
| Mather Group, LLC. | 450 | $666 | 0.00% |
| Strategic Investment Solutions, Inc. | 25 | $264 | 0.00% |
| Abich Financial Wealth Management LLC | 24 | $197 | 0.00% |
| International Assets Investment Management, LLC | 7 | $58 | 0.00% |
| CWM, LLC | 43 | $0 | 0.00% |
Sold out (39)
Institutions that held Rigel Pharmaceuticals Inc at the end of Q1 2024 and filed for Q2 2024 without it.